Biologic Drugs and Their Expanding Role in Retinal Disorder Care
Biologic drugs have become a central component in the treatment of back of the eye disorders. Derived from living systems, these therapies are engineered to interact with specific biological targets involved in retinal disease processes.
Their high specificity allows biologics to effectively control abnormal blood vessel growth and inflammation. Advances in protein engineering have enhanced their stability and durability within ocular tissues.
Ongoing innovation aims to improve delivery efficiency and extend treatment intervals. These improvements make biologic therapies more accessible and manageable for long-term care.
Biologics continue to redefine retinal treatment standards, offering powerful tools for disease control and vision preservation.